National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings, 72980 [2015-29739]
Download as PDF
<![CDATA[
wgreen on DSK2VPTVN1PROD with NOTICES
72980
Federal Register / Vol. 80, No. 225 / Monday, November 23, 2015 / Notices
notice will be posted on the NTP Web
site, and the submitter will be identified
by name, affiliation, and/or sponsoring
organization.
Public comment at this meeting is
welcome, with time set aside for the
presentation of oral comments on the
draft TRs. In addition to in-person oral
comments at the NIEHS, public
comments can be presented by
teleconference line. There will be 50
lines for this call; availability is on a
first-come, first-served basis. The lines
will be open from 9:00 a.m. until
approximately 4:00 p.m. EDT on
February 16, 2016, although oral
comments will be received only during
the formal public comment periods
indicated on the preliminary agenda.
The access number for the
teleconference line will be provided to
registrants by email prior to the meeting.
Each organization is allowed one time
slot for each draft TR. At least 7 minutes
will be allotted to each time slot, and if
time permits, may be extended to 10
minutes at the discretion of the chair.
Persons wishing to make an oral
presentation are asked to register online
at https://ntp.niehs.nih.gov/go/36051 by
February 9, 2016, indicate whether they
will present comments in-person or via
the teleconference line. If possible, oral
public commenters should send a copy
of their slides and/or statement or
talking points at that time. Written
statements can supplement and may
expand the oral presentation.
Registration for in-person oral
comments will also be available at the
meeting, although time allowed for
presentation by on-site registrants may
be less than that for registered speakers
and will be determined by the number
of speakers who register on-site.
Background Information on NTP Peer
Review Panels: NTP panels are
technical, scientific advisory bodies
established on an ‘‘as needed’’ basis to
provide independent scientific peer
review and advise the NTP on agents of
public health concern, new/revised
toxicological test methods, or other
issues. These panels help ensure
transparent, unbiased, and scientifically
rigorous input to the program for its use
in making credible decisions about
human hazard, setting research and
testing priorities, and providing
information to regulatory agencies about
alternative methods for toxicity
screening. The NTP welcomes
nominations of scientific experts for
upcoming panels. Scientists interested
in serving on an NTP panel should
provide current curriculum vitae to the
FOR FURTHER INFORMATION CONTACT. The
authority for NTP panels is provided by
42 U.S.C. 217a; section 222 of the Public
VerDate Sep<11>2014
14:25 Nov 20, 2015
Jkt 238001
Health Service (PHS) Act, as amended.
The panel is governed by the Federal
Advisory Committee Act, as amended (5
U.S.C. Appendix 2), which sets forth
standards for the formation and use of
advisory committees.
Dated: November 17, 2015.
John R. Bucher,
Associate Director, NTP.
[FR Doc. 2015–29733 Filed 11–20–15; 8:45 am]
BILLING CODE 4140–01–P
Contact Person: Najma Begum, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 749, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–8894,
begumn@niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: November 17, 2015.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
National Institutes of Health
[FR Doc. 2015–29739 Filed 11–20–15; 8:45 am]
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; PAR–14–301:
NIDDK Central Repositories Sample Access
from Clinical Trials (X01).
Date: February 1, 2016.
Time: 11:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Najma Begum, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 749, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–8894,
begumn@niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; RFA–DK–15–017:
Adherence Studies in Adolescents with CKD
or Urological Diseases (R01).
Date: February 8, 2016.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the National Advisory
Neurological Disorders and Stroke
Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Neurological Disorders and Stroke Council.
Date: February 4–5, 2016.
Open: February 4, 2016, 8:00 a.m. to 3:30
p.m.
Agenda: Report by the Director, NINDS;
Report by the Director, Division of
Extramural Research; and Administrative and
Program Developments.
Place: National Institutes of Health,
Building 31, C Wing, Conference Room 10,
31 Center Drive, Bethesda, MD 20892.
E:\FR\FM\23NON1.SGM
23NON1
]]>Agencies
[Federal Register Volume 80, Number 225 (Monday, November 23, 2015)]
[Notices]
[Page 72980]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-29739]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; PAR-14-301: NIDDK
Central Repositories Sample Access from Clinical Trials (X01).
Date: February 1, 2016.
Time: 11:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Najma Begum, Ph.D., Scientific Review Officer,
Review Branch, DEA, NIDDK, National Institutes of Health, Room 749,
6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 594-8894,
begumn@niddk.nih.gov.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; RFA-DK-15-017: Adherence
Studies in Adolescents with CKD or Urological Diseases (R01).
Date: February 8, 2016.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Najma Begum, Ph.D., Scientific Review Officer,
Review Branch, DEA, NIDDK, National Institutes of Health, Room 749,
6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 594-8894,
begumn@niddk.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
Dated: November 17, 2015.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-29739 Filed 11-20-15; 8:45 am]
BILLING CODE 4140-01-P
